US · ai · healthcare · monitoring
2 rounds we have observed, with the investors named in each. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series C · Mar 2026 · $65M
Goldman Sachs Alternatives lead, Growth Equity at Goldman Sachs Alternatives lead, IVP, Goldcrest
Reported by TechStartups and 1 other
Missing a round, or an investor who was in one? Tell us.